Avalo Therapeutics (AVTX) Gross Profit Growth (3y) (2020 - 2024)
Avalo Therapeutics (AVTX) Gross Profit Growth (3y) (2020 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 9.20% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.09% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 299.84% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 45.27% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 803.34% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 59.77% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 80.79% |
| 10 | Avalo Therapeutics | 854.16 Mn | 453.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -45.05% |
| Jun 30, 2024 | -28.16% |
| Mar 31, 2024 | -30.10% |
| Dec 31, 2023 | -17.65% |
| Sep 30, 2023 | -26.22% |
| Jun 30, 2023 | -27.07% |
| Mar 31, 2023 | -26.58% |
| Dec 31, 2022 | -54.60% |
| Sep 30, 2022 | 91.02% |
| Jun 30, 2022 | -76.77% |
| Mar 31, 2022 | -37.14% |
| Dec 31, 2021 | 63.39% |
| Sep 30, 2021 | -22.88% |
| Jun 30, 2021 | -0.90% |
| Mar 31, 2021 | -52.17% |
| Dec 31, 2020 | 3.60% |
| Sep 30, 2020 | -65.43% |
| Jun 30, 2020 | 99.87% |
| Mar 31, 2020 | 91.26% |